{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17772", "batch_size": 260, "batch_pos": 243, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain high-potency verbs, potent metaphors, superlative negative nouns, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_15844", "batch_size": 260, "batch_pos": 220, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "Describes securing vaccines, not realised impact with scale.", "method": "llm_batch", "batch_id": "batch_3_13780", "batch_size": 260, "batch_pos": 195, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_16936", "batch_size": 260, "batch_pos": 182, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports a fact about a vaccine deal but contains no explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_18148", "batch_size": 260, "batch_pos": 181, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment uses factual numbers ('up to 665,000 doses', '40 million vaccines'), not minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_11716", "batch_size": 260, "batch_pos": 159, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "No bare negation found.", "method": "llm_batch", "batch_id": "batch_7_17672", "batch_size": 260, "batch_pos": 158, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "The segment describes securing doses and options ('deal secures up to 665,000 doses', 'includes an option for a further 40 million vaccines') without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_18268", "batch_size": 260, "batch_pos": 77, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
